139 related articles for article (PubMed ID: 7787994)
1. Mucin antigens expression and Ki-67 labeling in breast cancer: the peculiarity in scirrhous carcinoma.
Nomoto M; Yonezawa S; Tokunaga M; Kim YS; Sato E
Pathol Int; 1995 Mar; 45(3):233-9. PubMed ID: 7787994
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of mucin carbohydrates and core proteins in human pancreatic tumors.
Osako M; Yonezawa S; Siddiki B; Huang J; Ho JJ; Kim YS; Sato E
Cancer; 1993 Apr; 71(7):2191-9. PubMed ID: 8384065
[TBL] [Abstract][Full Text] [Related]
3. Mucin antigen expression in gastric carcinomas of young and old adults.
Sakamoto H; Yonezawa S; Utsunomiya T; Tanaka S; Kim YS; Sato E
Hum Pathol; 1997 Sep; 28(9):1056-65. PubMed ID: 9308730
[TBL] [Abstract][Full Text] [Related]
4. Expression of proliferating cell nuclear antigen in invasive ductal carcinoma of the breast.
Horiguchi J; Iino Y; Takei H; Morishita Y; Nakajima T
Jpn J Clin Oncol; 1994 Apr; 24(2):79-84. PubMed ID: 7908995
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors.
Tashiro Y; Yonezawa S; Kim YS; Sato E
Hum Pathol; 1994 Apr; 25(4):364-72. PubMed ID: 8163269
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic significance of an immunohistochemical expression of p27 in scirrhous carcinoma of the breast.
Nozoe T; Oyama T; Mori E; Uramoto H; Takenoyama M; Hanagiri T; Sugio K; Yasumoto K
Breast Cancer; 2007; 14(3):277-80. PubMed ID: 17690504
[TBL] [Abstract][Full Text] [Related]
7. Expression of mucin antigens and Lewis X-related antigens in carcinomas and dysplasia of the pharynx and larynx.
Itoh T; Yonezawa S; Nomoto M; Ueno K; Kim YS; Sato E
Pathol Int; 1996 Sep; 46(9):646-55. PubMed ID: 8905873
[TBL] [Abstract][Full Text] [Related]
8. L-Type amino acid transporter 1 (LAT1) expression in lymph node metastasis of gastric carcinoma: Its correlation with size of metastatic lesion and Ki-67 labeling.
Ichinoe M; Yanagisawa N; Mikami T; Hana K; Nakada N; Endou H; Okayasu I; Murakumo Y
Pathol Res Pract; 2015 Jul; 211(7):533-8. PubMed ID: 25908107
[TBL] [Abstract][Full Text] [Related]
9. Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-α expression in invasive ductal breast cancer patients and correlations with prognosis.
Yan J; Liu XL; Han LZ; Xiao G; Li NL; Deng YN; Yin LC; Ling LJ; Yu XY; Tan CL; Huang XP; Liu LX
Asian Pac J Cancer Prev; 2015; 16(2):823-9. PubMed ID: 25684532
[TBL] [Abstract][Full Text] [Related]
10. Simple mucin-type carbohydrate antigens (Tn, sialosyl-Tn and T) in gastric mucosa, carcinomas and metastases.
David L; Nesland JM; Clausen H; Carneiro F; Sobrinho-Simões M
APMIS Suppl; 1992; 27():162-72. PubMed ID: 1520525
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic significance of the S-phase and MIB1 (Ki-67) proliferation parameters in node-negative breast carcinoma].
Harbeck N; Dettmar P; Thomssen Ch; Pache L; Ziffer P; Fizi K; Jänicke F; Nathrath W; Schmitt M; Graeff H
Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():142-7. PubMed ID: 8672914
[TBL] [Abstract][Full Text] [Related]
12. Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer.
Rudolph P; Alm P; Heidebrecht HJ; Bolte H; Ratjen V; Baldetorp B; Fernö M; Olsson H; Parwaresch R
J Natl Cancer Inst; 1999 Feb; 91(3):271-8. PubMed ID: 10037106
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas.
Iwamoto M; Shinohara H; Miyamoto A; Okuzawa M; Mabuchi H; Nohara T; Gon G; Toyoda M; Tanigawa N
Int J Cancer; 2003 Mar; 104(1):92-7. PubMed ID: 12532424
[TBL] [Abstract][Full Text] [Related]
14. Expression of mucin carbohydrates and core proteins in carcinomas of the ampulla of Vater: their relationship to prognosis.
Kitamura H; Yonezawa S; Tanaka S; Kim YS; Sato E
Jpn J Cancer Res; 1996 Jun; 87(6):631-40. PubMed ID: 8766528
[TBL] [Abstract][Full Text] [Related]
15. Discordance of hormone receptor, human epidermal growth factor receptor-2, and Ki-67 between primary breast cancer and synchronous axillary lymph node metastasis.
Kinoe H; Yamanouchi K; Kuba S; Morita M; Sakimura C; Kanetaka K; Takatsuki M; Abe K; Yano H; Matsumoto M; Otsubo R; Hayashida N; Nagayasu T; Eguchi S
J BUON; 2018 Dec; 23(7):60-66. PubMed ID: 30722113
[TBL] [Abstract][Full Text] [Related]
16. Decreased nm23 expression, but not Ki-67 labeling index, is significantly correlated with lymph node metastasis of breast invasive ductal carcinoma.
Terasaki-Fukuzawa Y; Kijima H; Suto A; Takeshita T; Iezumi K; Sato S; Yoshida H; Sato T; Shimbori M; Shiina Y
Int J Mol Med; 2002 Jan; 9(1):25-9. PubMed ID: 11744991
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of c-erbB-2 expression in invasive ductal carcinoma of the breast.
Horiguchi J; Iino Y; Takei H; Morishita Y
Jpn J Clin Oncol; 1995 Aug; 25(4):119-23. PubMed ID: 7666587
[TBL] [Abstract][Full Text] [Related]
18. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
19. Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinoma.
Bevilacqua P; Verderio P; Barbareschi M; Bonoldi E; Boracchi P; Dalla Palma P; Gasparini G
Breast Cancer Res Treat; 1996; 37(2):123-33. PubMed ID: 8750580
[TBL] [Abstract][Full Text] [Related]
20. Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas.
Haerslev T; Jacobsen GK; Zedeler K
Breast Cancer Res Treat; 1996; 37(2):101-13. PubMed ID: 8750578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
